Replies to post #317536 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Targeting PS for the treatment of disease.

Modified Annexin A5 (AnxA5MOD)Immunotherapy Delivery Platform

This exactly what I was thinking when I kept say Annexin V.

I believe this is an infringement of the UTSW PATENTS.

wook